Debating UK approval of gene editing in human embryos<br> [MP3]
By Flagged
| 02. 01. 2016
[With CGS's Marcy Darnovsky]
Download audio (MP3)
In a landmark decision that some ethicists warned is a step down the path toward "designer babies," Britain gave scientists approval Monday to conduct experiments in which they will try to edit the genes in human embryos.
Host: Larry Mantle
Guests:
- Ronald Bailey, Science Correspondent for “Reason” magazine and Reason.com; Author of “The End of Doom: Environmental Renewal in the Twenty-first Century”
- Marcy Darnovsky, Ph.D., executive director of the Center for Genetics and Society, a nonprofit organization working to encourage responsible uses and effective societal governance of human genetic, reproductive, and biomedical technologies
More info:
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
